Company intelligence
NRT
Next-generation innovative radiopharmaceuticals for cancer
Biotechnology Research
San Diego, US
15 employees
Founded 2016
2 public signals
About NRT
NRT is a global radiopharmaceutical innovator, founded in 2016. With 400+ specialists, NRT delivers end-to-end solutions from isotope production to drug commercialization. Our portfolio spans isotopes such as Ac-225, Lu-177, and Cu-64, proprietary platforms including iCleave™ linkers and TareSphere™ Y-90 microspheres, and FDA-cleared IND candidates for solid tumor diagnosis and therapy. NRT is committed to becoming a global leader in nuclear medicine technology.
Verified activity
Signals from NRT
2 published signals